Discontinued — last reported Q4 '25
Brookfield Asset Management Interest Paid decreased by 57.7% to $11.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 120.0%, from $5.00M to $11.00M. Over 2 years (FY 2023 to FY 2025), Interest Paid shows an upward trend with a 210.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.25M | $2.25M | $2.25M | $2.25M | $2.00M | $5.00M | $4.00M | $5.00M | $12.00M | $38.00M | $26.00M | $11.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -11.1% | +150.0% | -20.0% | +25.0% | +140.0% | +216.7% | -31.6% | -57.7% |
| YoY Change | — | — | — | — | -11.1% | +122.2% | +77.8% | +122.2% | +500.0% | +660.0% | +550.0% | +120.0% |